Editorial: Not so nosocomial anymore: The growing threat of community-acquired clostridium difficile

American Journal of Gastroenterology

Volumn 107, Issue 1, 2012, Pages 96-98

  Leffler, Daniel A ^a   Lamont, J Thomas ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM DIFFICILE INFECTION; COMMUNICABLE DISEASE; DEMOGRAPHY; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION RISK; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; MALE;

EID: 84855416808     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.404     Document Type: Review

References (17)

1. Hall I, O ' Tool E. Intestinal fl ora in newborn infants with a description of a new pathogenic anaerobe, Bacillus difficilis. Am J Dis Child 1935; 49: 390-3.
2. Bartlett JG, Moon N, Chang TW et al. Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology 1978; 75: 778-82. (Pubitemid 9040959)
3. Keighley MR, Burdon DW, Alexander-Williams J et al. Diarrhoea and pseudomembranous colitis aft er gastrointestinal operations. A prospective study. Lancet 1978; 2: 1165-7. (Pubitemid 9084068)
4. Khanna SPDS, Aronson SL, Kammer PP et al. The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol 2012;107:89-95 (this issue).
5. Hirschhorn LR, Trnka Y, Onderdonk A et al. Epidemiology of community-acquired Clostridium difficile-associated diarrhea. J Infect Dis 1994; 169: 127-33.
6. McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 2006; 12: 409-15.
7. Dial S, Kezouh A, Dascal A et al. Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. CMAJ 2008; 179: 767-72.
8. Naggie S, Miller BA, Zuzak KB et al. A case-control study of communityassociated Clostridium difficile infection: no role for proton pump inhibitors. Am J Med 124; 276: e1-7.
9. Kutty PK, Benoit SR, Woods CW et al. Assessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005. Infect Control Hosp Epidemiol 2008; 29: 197-202. (Pubitemid 351269184)
10. Jangi S, Lamont JT. Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life. J Pediatr Gastroenterol Nutr 2010; 51: 2-7.
11. Leffler DA, Lamont JT. Treatment of Clostridium difficile-associated disease. Gastroenterology 2009; 136: 1899-912.
12. Gould LH, Limbago B. Clostridium difficile in food and domestic animals: a new foodborne pathogen? Clin Infect Dis 2010; 51: 577-82.
13. Rupnik M. Is Clostridium difficile-associated infection a potentially zoonotic and foodborne disease? Clin Microbiol Infect 2007; 13: 457-9. (Pubitemid 46563496)
14. Kelly CP, LaMont JT. Clostridium difficile-more difficult than ever. N Engl J Med 2008; 359: 1932-40.
15. Arumugam M, Raes J, Pelletier E et al. Enterotypes of the human gut microbiome. Nature 2011; 473: 174-80.
16. Jiang MH, Zhu L, Jiang JG. Immunoregulatory actions of polysaccharides from Chinese herbal medicine. Expert Opin Ther Targets 2010; 14: 1367-402.
17. Durber J, Otley A. Complementary and alternative medicine in infl ammatory bowel disease: keeping an open mind. Expert Rev Clin Immunol 2005; 1: 277-92.